MEFS Exchange course & Symposium- ASRM2012
Symposium - Middle East Fertility Society Symposium - An OHSS-Free IVF
Clinic: Should This Be a Goal and Is It Possible?
Date: October 23, 2012
4:15 pm - 6:15 pm
Room 21 - San Diego Convention Center
Suheil J. Muasher, M.D. (Chair), The Muasher Center for Fertility and IVF
James M. Goldfarb, M.D., Cleveland Clinic
Paul Devroey, M.D., Ph.D., Centre for Reproductive Medicine, Brussels
Botros B. Rizk, M.D., University of South Alabama
IVF Clinic: Should This Be a Goal and Is It Possible?
Assessment and Description
Ovarian hyperstimulation syndrome (OHSS) is
one of the most morbid complications of in vitro fertilization (IVF)
treatment with an estimated mortality rate of 3 per 100,000 stimulated
cycles. The incidence that is usually quoted to patients is 2% to 3%, but it
is much higher in patients who are young, have a lean body mass and are
hyper-responders (more than 15 oocytes recruited) to stimulation. This live
course will educate practitioners on the recognition of patients at
increased risk so that all measures are taken to prevent OHSS. IVF success
should be defined not only by successful live births but also by eliminating
OHSS in patients at risk.
At the conclusion of this session,
participants should be able to:
Identify patient profiles that are at risk of developing OHSS.
Assess measures that will help eliminate the syndrome.
Measure success from IVF by live births as well as by absence of
After participating in this session, in my
practice I will:
Use the same dosage of gonadotropins for all my IVF patients.
Strive to recruit the maximum number of oocytes for all
Use milder forms of stimulation in patients at risk for OHSS.
Not worry about OHSS as it is very rare and can be treated
successfully in most patients.
Not applicable to my area of practice.